ES2721270T3 - Composiciones de profármaco de aripiprazol - Google Patents
Composiciones de profármaco de aripiprazol Download PDFInfo
- Publication number
- ES2721270T3 ES2721270T3 ES15750750T ES15750750T ES2721270T3 ES 2721270 T3 ES2721270 T3 ES 2721270T3 ES 15750750 T ES15750750 T ES 15750750T ES 15750750 T ES15750750 T ES 15750750T ES 2721270 T3 ES2721270 T3 ES 2721270T3
- Authority
- ES
- Spain
- Prior art keywords
- aripiprazole prodrug
- surface stabilizer
- aripiprazole
- particles
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Quinoline Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composición que comprende: (a) una población de partículas de un profármaco de aripiprazol que tiene un tamaño de partícula basado en volumen (Dv50) de entre 50 y 700 nm según lo determinado mediante técnicas de dispersión de la luz; (b) al menos un estabilizador superficial que comprende un componente adsorbido que se adsorbe sobre la superficie de las partículas del profármaco de aripiprazol y un componente libre disponible para la solubilización del profármaco de aripiprazol, en la que la proporción en peso del profármaco de aripiprazol con respecto al estabilizador superficial está en el intervalo de 17:1 a 26:1, y en la que el profármaco de aripiprazol tiene la fórmula:**Fórmula** en la que n es cero o un número entero inferior a 20, en la que el al menos un estabilizador superficial se selecciona del grupo que consiste en carboximetilcelulosa y ésteres de ácidos grasos de polioxietilensorbitán.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462038665P | 2014-08-18 | 2014-08-18 | |
EP14181328 | 2014-08-18 | ||
PCT/EP2015/068872 WO2016026822A1 (en) | 2014-08-18 | 2015-08-17 | Aripiprazole prodrug compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2721270T3 true ES2721270T3 (es) | 2019-07-30 |
ES2721270T5 ES2721270T5 (es) | 2022-07-21 |
Family
ID=53872058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES15750750T Active ES2721270T5 (es) | 2014-08-18 | 2015-08-17 | Composiciones de profármaco de aripiprazol |
Country Status (9)
Country | Link |
---|---|
JP (2) | JP6826167B2 (es) |
CY (1) | CY1121594T1 (es) |
DK (1) | DK3182958T4 (es) |
ES (1) | ES2721270T5 (es) |
HR (1) | HRP20190642T2 (es) |
HU (1) | HUE043169T2 (es) |
LT (2) | LT3182958T (es) |
PT (1) | PT3182958T (es) |
TR (1) | TR201905694T4 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT3182958T (lt) * | 2014-08-18 | 2019-06-25 | Alkermes Pharma Ireland Limited | Aripiprazolo provaisto kompozicijos |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT3182958T (lt) * | 2014-08-18 | 2019-06-25 | Alkermes Pharma Ireland Limited | Aripiprazolo provaisto kompozicijos |
AU2015306198B2 (en) * | 2014-08-18 | 2021-02-25 | Alkermes Pharma Ireland Limited | Aripiprazole prodrug compositions |
-
2015
- 2015-08-17 LT LTEP15750750.0T patent/LT3182958T/lt unknown
- 2015-08-17 ES ES15750750T patent/ES2721270T5/es active Active
- 2015-08-17 TR TR2019/05694T patent/TR201905694T4/tr unknown
- 2015-08-17 LT LTEP19154013.7T patent/LT3508196T/lt unknown
- 2015-08-17 HR HRP20190642TT patent/HRP20190642T2/hr unknown
- 2015-08-17 HU HUE15750750A patent/HUE043169T2/hu unknown
- 2015-08-17 PT PT15750750T patent/PT3182958T/pt unknown
- 2015-08-17 DK DK15750750.0T patent/DK3182958T4/da active
-
2019
- 2019-04-19 CY CY20191100430T patent/CY1121594T1/el unknown
- 2019-08-07 JP JP2019145176A patent/JP6826167B2/ja active Active
-
2021
- 2021-01-14 JP JP2021004441A patent/JP7157830B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
RU2019134055A (ru) | 2020-02-03 |
DK3182958T4 (da) | 2022-07-04 |
ES2721270T5 (es) | 2022-07-21 |
DK3182958T3 (da) | 2019-05-06 |
HUE043169T2 (hu) | 2019-08-28 |
JP7157830B2 (ja) | 2022-10-20 |
HRP20190642T2 (hr) | 2022-07-08 |
LT3182958T (lt) | 2019-06-25 |
LT3508196T (lt) | 2021-09-10 |
CY1121594T1 (el) | 2020-05-29 |
HRP20190642T4 (hr) | 2022-06-24 |
JP6826167B2 (ja) | 2021-02-03 |
HRP20190642T1 (hr) | 2019-05-31 |
TR201905694T4 (tr) | 2019-05-21 |
PT3182958T (pt) | 2019-05-23 |
JP2021059604A (ja) | 2021-04-15 |
JP2020007316A (ja) | 2020-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR127861A2 (es) | Composición farmacéutica que comprende inhibidores del proteasoma peptídico y ciclodextrina | |
CL2016000882A1 (es) | Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15). | |
BR112016024357A2 (pt) | composições de insulina de ação rápida | |
BR112017008720A2 (pt) | métodos e composições relacionados a nanoveículos sintéticos com rapamicina em um estado supersaturado, estável | |
MY165124A (en) | Semifluorinated alkane compositions | |
BR112015021923A2 (pt) | composições de limpeza contendo uma polieteramina, um polímero removedor de sujeiras e uma carboximetil-celulose | |
BR112015032338A2 (pt) | composições e artigos para cuidados pessoais | |
UA113440C2 (xx) | Сполуки тетрагідропіразолопіримідину | |
BR112017009277A2 (pt) | compostos de silicone | |
BR112015023321A2 (pt) | dispersões submicrômetras substancialmente livres de surfactante e alimento com as mesmas | |
BR112016023676A2 (pt) | pó de sinterização com baixa pressão | |
PE20151793A1 (es) | Compuestos heterociclicos moduladores de la piruvato quinasa y composiciones que los contienen | |
PE20160605A1 (es) | Formulaciones de inhibidores de la syk | |
CR20160499A (es) | Composiciones estables de yodo no en complejo y métodos de uso | |
BR112015012841A2 (pt) | composição imunogênica, vacina, e, uso de uma composição imunogênica | |
BR112015023387A2 (pt) | composições lipídicas de racecodotril | |
BR112017002926A2 (pt) | composições e método para aprimorar o perfil de liberação farmacocinético inicial in vivo | |
BR112016008502A2 (pt) | Composição refrigerante | |
BR112015001728B8 (pt) | composições de condicionador | |
UY35824A (es) | Preparación farmacéutica y forma de su producción y uso | |
BR112014018094A2 (pt) | composição de mistura contendo siloxanos amino-funcionais, partículas hidrofóbicas e silicones de elevado peso molecular e o seu uso para tratamento de couro | |
BR112015022940A2 (pt) | composições líquidas de racecadotrila | |
CL2015002702A1 (es) | Composiciones farmacéuticas micronizadas. | |
ES2721270T3 (es) | Composiciones de profármaco de aripiprazol | |
MX2022010827A (es) | Composiciones de microesferas de gas encapsulado en lipidos y metodos relacionados. |